Including the $4.4 billion raised by Didi, a total of 36 Chinese companies have sold shares in New York this year, raising a total of $12.6 billion, according to Dealogic. According to anonymously-sourced whispers, LinkDoc, a provider of cancer-focused health care services using big data and artificial intelligence, had planned to sell 10.8MM shares priced between $17.50 and $19.50 each. On Wednesday, LinkDoc updated its prospectus to cite new risks from Beijing, in what was perhaps a hint that the deal would soon be pulled.
It was seen as raising as much as 211 million by selling 10.8 million shares priced. The company had been expected to price the deal today, which means it would have likely started trading some time next week. LinkDoc, which filed for its IPO in June, was due to price its offering after the US market close on Thursday. However, Nikkei reported that "market volatility, regulatory uncertainty and fear of angering Chinese regulators have prompted the company to cancel the offering, one of the people said. LinkDoc had planned to raise up to $210MM on the Nasdaq, but it closed its book on Wednesday despite reportedly strong demand. According to anonymously-sourced whispers, LinkDoc, a provider of cancer-focused health care services using big data and artificial intelligence, had planned to sell 10.8MM shares priced between 17.50 and 19.50 each. They include Alibaba-backed LinkDoc and SoftBank- and Tencent-backed fitness app Keep.
0 kommentar(er)
